Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.

Leosuthamas, Pornsawan; Narongroeknawin, Pongthorn; Chaiamnuay, Sumapa; Asavatanabodee, Paijit; Pakchotanon, Rattapol

Leosuthamas, Pornsawan; Narongroeknawin, Pongthorn; Chaiamnuay, Sumapa; Asavatanabodee, Paijit; Pakchotanon, Rattapol.

Afiliação

Leosuthamas P; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Narongroeknawin P; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Chaiamnuay S; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Asavatanabodee P; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Pakchotanon R; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

Int J Rheum Dis ; 26(4): 667-672, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36802112

Assuntos

Lúpus Eritematoso Sistêmico; Nefrite Lúpica; Humanos; Nefrite Lúpica/diagnóstico; Nefrite Lúpica/tratamento farmacológico; Índice de Gravidade de Doença; Lúpus Eritematoso Sistêmico/diagnóstico; Lúpus Eritematoso Sistêmico/tratamento farmacológico; Resultado do Tratamento; Reino Unido

Palavras-chave

disease activity index; systemic lupus erythematosus; treatment outcome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google